Quick answer
British Patient Capital provides indirect equity for high-growth UK companies via the venture and growth funds it backs — not direct investment. Founders raise from BPC-backed managers in the normal way. The programme exists to deepen UK long-term capital across life sciences, deep tech, climate and digital. Most relevant after Series A, when a company is targeting a £10m+ growth round and wants UK-anchored, longer-duration capital alongside international syndicate partners.
Advisor summary
British Patient Capital is a equity. UK government-backed investor in venture and growth capital funds that back high-growth UK businesses. Businesses receive equity via portfolio funds, not directly. Based on the published criteria, British Patient Capital is most relevant to growth businesses; organisations working in Life Sciences, Technology & Software; applicants based in United Kingdom. It typically supports activities aligned with Innovation & R&D, Growth & Equity Capital — applications that demonstrate a clear, evidenced link to one of these objectives tend to score better against the published assessment framework. Eligibility focus: High-growth UK companies backed by funds in the British Patient Capital portfolio. No direct applications. British Patient Capital is most useful when you need growth capital where the team is comfortable with dilution and governance changes. If your situation does not match that profile, the Alternative Routes section below lists more suitable options before you commit time to an application. Before applying, confirm the scheme is currently open on the official source page — funding amounts, deadlines and round-by-round priorities for British Patient Capital can change between calls.
Key takeaways
- Funding type: equity.
- Target stage: growth.
- Geographic coverage: United Kingdom.
- Aligned to objectives such as Innovation & R&D, Growth & Equity Capital.
- Industry relevance: Life Sciences, Technology & Software.
- Always validate live eligibility and timing on the official source before applying.
Who this is for
British Patient Capital is most relevant to: - growth businesses that match the published stage definition - organisations operating in Life Sciences, Technology & Software - applicants based in United Kingdom - teams whose planned activity advances Innovation & R&D or Growth & Equity Capital - organisations that can evidence eligibility, deliverability and value-for-money against the scheme's published criteria Use the eligibility section above to validate fit before applying.
Real-world use cases
- Innovation & R&D projects seeking equity support consistent with the published scope of British Patient Capital.
- Growth & Equity Capital projects seeking equity support consistent with the published scope of British Patient Capital.
- Life Sciences businesses where the planned activity matches the eligible activity list and can be delivered within the scheme's reporting window.
- Technology & Software businesses where the planned activity matches the eligible activity list and can be delivered within the scheme's reporting window.
- Projects delivered in United Kingdom where the applicant is registered and trading in the eligible geography.
What to prepare
- Read the official guidance end-to-end and note every mandatory criterion.
- Confirm the current round is open and check the live deadline on the official source.
- Pull recent management accounts and statutory financials covering the requested period.
- Draft a clear project description: problem, approach, milestones, outputs.
- Prepare a defensible budget that ties each cost line to a project milestone.
- Identify and brief any partners, suppliers or supporting referees in advance.
- Leave time for internal review and sign-off before submission.
- Capture the assumptions behind any quantitative claims (jobs created, emissions saved, additional R&D spend) so they can be defended at assessment.
Common mistakes
- Pitching the product instead of evidencing the market opportunity and traction.
- Unrealistic valuation expectations not anchored in comparable rounds or revenue.
- Cap table issues — undocumented founder splits, missed option pool, dormant shareholders.
- Skipping diligence preparation: data room, IP assignments, customer references.
- Underestimating how long an equity round takes to close.
- Failing to make the connection to Innovation & R&D explicit — assessors should not have to infer how British Patient Capital fits the project.
Why applications get rejected
- Market size, defensibility or business model not yet evidenced.
- Team gaps in critical functions for the next 12–18 months.
- Traction inconsistent with the stage being raised for.
- Cap table or governance issues that block clean investment.
- Misalignment with the investor's mandate, sector or geography.
- Applicant or project location does not satisfy the geographic eligibility for British Patient Capital (United Kingdom).
Alternative funding routes
- Consider related equity routes such as Kent and Medway Growth Hub, Tees Valley Investment Zone Business Support, Innovate UK Innovation Loans — see the Related grants section for direct links.
- Use side-by-side comparisons such as British Patient Capital vs Venture Capital and Future Fund: Breakthrough vs Angel Investment to weigh British Patient Capital against the closest alternatives before committing.
- The decision guides What comes after Start Up Loans? and Should I apply for a grant, a loan or investment? walk through the trade-offs in plain English.
- Schemes targeting Innovation & R&D from other providers may offer complementary or fallback coverage if British Patient Capital is not a fit this round.
- Non-dilutive alternatives (grants, R&D tax relief) can extend runway before raising equity.
Typical funding journey
- 1Preparation — refine the narrative, financial model and data room.
- 2Targeting — shortlist investors aligned with stage, sector and geography.
- 3Outreach — warm introductions and a structured outreach plan.
- 4First meetings — qualify mutual fit before deep diligence.
- 5Diligence — commercial, technical, financial and legal review.
- 6Term sheet — negotiate valuation, governance and key protective rights.
- 7Completion — legal work, signing and post-close reporting set-up.
Frequently asked questions
Who is eligible to apply for British Patient Capital?
British Patient Capital is aimed at growth-stage businesses. It is available to applicants in United Kingdom. Industry focus areas include Life Sciences, Technology & Software. Always confirm the live eligibility criteria on the official source page before applying — eligibility rules can change between rounds.
What does British Patient Capital fund?
As a equity programme, British Patient Capital typically supports activities consistent with its published objectives (Innovation & R&D, Growth & Equity Capital). Specific eligible costs and project types are defined in the scheme's published guidance — review the official source page for the current list.
How competitive is British Patient Capital?
Published competitiveness figures vary by round and are not always disclosed. Treat any scheme with limited published cost as competitive: prepare as if you were one of many strong applicants, and lean on the assessment criteria when building your application.
What preparation is needed before applying to British Patient Capital?
Start by reading the official guidance end-to-end and mapping your project against each assessment criterion. Pull together core supporting evidence early — typically organisation details, recent financials, a clear project description, milestones and a budget. Leave time for internal review and, where relevant, partner or advisor sign-off before submission.
What documents are usually required for British Patient Capital?
Most schemes ask for organisation details, recent financial information, a project description with milestones, and a budget breakdown. Always check the official source page for the definitive document list for the current round.
What alternatives exist if British Patient Capital is not a fit?
The Alternative Routes section above lists related funding paths. As a general rule, look for schemes targeting the same objective or stage from different providers, and consider blending sources (for example combining a grant with a loan or equity) where the project size warrants it.
How do you apply for British Patient Capital?
Application routing is set out on the official source page linked above — confirm the current round is open before starting an application.
When should you start preparing for British Patient Capital?
Treat preparation as a multi-week process for most schemes. Begin gathering financials, project documentation and supporting evidence as soon as you decide to apply — leaving preparation to the final week typically shows in the quality of the application.
What happens after you apply to British Patient Capital?
Applications are typically logged, screened for eligibility, then assessed against the published criteria. Be ready to respond quickly to clarification requests during review, and keep contact details up to date so decision notifications are not missed.
Can British Patient Capital be combined with other funding or support?
Equity investment is often blended with non-dilutive funding (grants, tax relief) to extend runway between rounds. Read the scheme's published rules on combined funding before committing — the answer changes case-by-case.
What should applicants do before applying to British Patient Capital?
Validate that British Patient Capital is genuinely the best fit — the Alternative Routes section above lists other options worth comparing first. Re-read the official guidance and map your project, organisation and budget to each scoring criterion. Walk through the Eligibility section line by line and gather evidence for every requirement. Speak to anyone in your network who has been through this scheme recently — round-by-round priorities and assessor focus shift.
What makes a strong application to British Patient Capital?
Strong British Patient Capital applications evidence fit against every published criterion rather than restating the project's ambition. Use concrete numbers, dated milestones and named partners wherever possible — assessors reward specificity. Make the link to Innovation & R&D and Growth & Equity Capital explicit; do not leave assessors to infer it.
When might another funding route be more suitable than British Patient Capital?
If you would prefer to avoid dilution and the project qualifies as R&D, grants and tax reliefs can extend runway without giving up ownership. See the Alternative Routes section above for specific suggestions.
What happens after British Patient Capital is awarded?
Funded organisations typically sign a grant or facility agreement that sets out drawdown conditions, reporting cadence and any claw-back triggers. Plan for periodic progress reports, evidence of spend and — for larger awards — independent monitoring or audit.
How should organisations prepare supporting evidence for British Patient Capital?
Gather evidence in the order assessors will read it: organisation legitimacy first, then eligibility, then project fit, then budget and impact. Even where a document list is not published, prepare financials, a project plan with milestones, and budget evidence as a baseline. Where claims are quantitative (job creation, emissions reduction, additional R&D spend), document the assumption behind each number.
Read end-to-end by a FundingAtlas editor against the official source.
Funding amount
Varies
Region
United Kingdom
Stage
Growth
Provider
British Business Bank — British Patient Capital
Advisor summary
British Patient Capital is a equity. UK government-backed investor in venture and growth capital funds that back high-growth UK businesses. Businesses receive equity via portfolio funds, not directly. Based on the published criteria, British Patient Capital is most relevant to growth businesses; organisations working in Life Sciences, Technology & Software; applicants based in United Kingdom. It typically supports activities aligned with Innovation & R&D, Growth & Equity Capital — applications that demonstrate a clear, evidenced link to one of these objectives tend to score better against the published assessment framework. Eligibility focus: High-growth UK companies backed by funds in the British Patient Capital portfolio. No direct applications. British Patient Capital is most useful when you need growth capital where the team is comfortable with dilution and governance changes. If your situation does not match that profile, the Alternative Routes section below lists more suitable options before you commit time to an application. Before applying, confirm the scheme is currently open on the official source page — funding amounts, deadlines and round-by-round priorities for British Patient Capital can change between calls.
Key takeaways
- Funding type: equity.
- Target stage: growth.
- Geographic coverage: United Kingdom.
- Aligned to objectives such as Innovation & R&D, Growth & Equity Capital.
- Industry relevance: Life Sciences, Technology & Software.
- Always validate live eligibility and timing on the official source before applying.
Who this is for
British Patient Capital is most relevant to: - growth businesses that match the published stage definition - organisations operating in Life Sciences, Technology & Software - applicants based in United Kingdom - teams whose planned activity advances Innovation & R&D or Growth & Equity Capital - organisations that can evidence eligibility, deliverability and value-for-money against the scheme's published criteria Use the eligibility section above to validate fit before applying.
Probably not for you if…
Pre-seed founders, lifestyle businesses, companies seeking grant funding, and any business looking to apply to British Patient Capital directly — it does not invest into companies. Companies that are not investment-ready (no traction, no team, no defined market) should not approach the underlying funds yet.
Real-world use cases
Series A led by a BPC-backed VC
Growth round with patient capital
Deeptech follow-on
What to prepare before applying
- 1
Read the official guidance end-to-end and note every mandatory criterion.
- 2
Confirm the current round is open and check the live deadline on the official source.
- 3
Pull recent management accounts and statutory financials covering the requested period.
- 4
Draft a clear project description: problem, approach, milestones, outputs.
- 5
Prepare a defensible budget that ties each cost line to a project milestone.
- 6
Identify and brief any partners, suppliers or supporting referees in advance.
- 7
Leave time for internal review and sign-off before submission.
- 8
Capture the assumptions behind any quantitative claims (jobs created, emissions saved, additional R&D spend) so they can be defended at assessment.
Common mistakes
Pitching the product instead of evidencing the market opportunity and traction.
Unrealistic valuation expectations not anchored in comparable rounds or revenue.
Cap table issues — undocumented founder splits, missed option pool, dormant shareholders.
Skipping diligence preparation: data room, IP assignments, customer references.
Underestimating how long an equity round takes to close.
Failing to make the connection to Innovation & R&D explicit — assessors should not have to infer how British Patient Capital fits the project.
Common rejection reasons
Market size, defensibility or business model not yet evidenced.
Team gaps in critical functions for the next 12–18 months.
Traction inconsistent with the stage being raised for.
Cap table or governance issues that block clean investment.
Misalignment with the investor's mandate, sector or geography.
Applicant or project location does not satisfy the geographic eligibility for British Patient Capital (United Kingdom).
Alternative funding routes
Consider related equity routes such as Kent and Medway Growth Hub, Tees Valley Investment Zone Business Support, Innovate UK Innovation Loans — see the Related grants section for direct links.
Use side-by-side comparisons such as British Patient Capital vs Venture Capital and Future Fund: Breakthrough vs Angel Investment to weigh British Patient Capital against the closest alternatives before committing.
The decision guides What comes after Start Up Loans? and Should I apply for a grant, a loan or investment? walk through the trade-offs in plain English.
Schemes targeting Innovation & R&D from other providers may offer complementary or fallback coverage if British Patient Capital is not a fit this round.
Non-dilutive alternatives (grants, R&D tax relief) can extend runway before raising equity.
Typical funding journey
- 1
Shortlist managers
- 2
Warm introductions
- 3
First meetings
- 4
Term sheet and DD
- 5
Completion
Advisor view
British Patient Capital is a subsidiary of the British Business Bank. It is a fund-of-funds: it commits capital to UK-focused venture and growth funds, which then invest in companies. For founders, the practical implication is that you never "apply" to British Patient Capital — you build a relationship with the underlying funds in its portfolio, the same way you would with any other VC. The strategic value of knowing about British Patient Capital is two-fold: (1) it materially expands the pool of UK-active growth capital, which is structurally thinner than in the US, and (2) the published portfolio is a high-quality, curated list of UK-investing funds you can map against your stage and sector.
Usually too early when
Advisor signal
You are pre-revenue with no defined product, no team, and no investor-ready data room. Patient capital funds typically engage with companies that already have a Series A profile — meaningful revenue or technical milestones, a credible team, and a defined route to a large market.
Eligibility
High-growth UK companies backed by funds in the British Patient Capital portfolio. No direct applications.
Evidence you'll need
Investment-grade pitch deck, financials and KPI traction; standard fund due diligence.
Application timeline
There is no central British Patient Capital application. Engagement with each underlying fund typically runs 3–9 months from first meeting to term sheet, plus a further 4–12 weeks of diligence and legals to close. Plan investor processes well in advance of when you need the cash.
Common reasons applications fail
Approaching the wrong stage of fund, weak or generic outreach, an unconvincing data room, unrealistic valuation expectations, founder team gaps, and a market thesis the fund does not believe is large or defensible enough.
What improves your odds
Map yourself against specific funds in the British Patient Capital portfolio (stage, sector, cheque size) rather than approaching the whole list. Have a clean data room, a credible 5-year plan, and ideally a warm introduction. Build relationships 6–12 months before you need to close. Where relevant, use prior Innovate UK grants and SEIS/EIS rounds as proof points of capital efficiency.
Typical successful applicant
A UK-headquartered scale-up with a strong technical or market moat, an experienced leadership team, demonstrable traction (revenue or hard technical milestones), and a credible plan to deploy £2m–£50m+ of equity to capture a defined large market.
Common misconceptions
- "You apply to British Patient Capital." You do not — you raise from its portfolio funds. - "It's a UK government grant scheme." It is institutional equity via a government-backed investor. - "It's for early-stage startups." Most underlying funds invest from Series A upwards; deep-tech and life-sciences specialists may go earlier but still expect investor-grade evidence. - "Being UK-based is enough." Stage, sector fit and quality of team and traction matter at least as much as geography.
What happens next
Review the British Patient Capital portfolio of funds and shortlist those whose stage, sector and cheque size match your raise. Approach them directly — ideally via a warm introduction from another founder, an existing investor, or an Innovate UK Business Growth specialist. Run a structured process across several funds in parallel rather than sequentially.
What comes next
After a first round from a British Patient Capital portfolio fund, the typical progression is (a) follow-on rounds led by the same fund or syndicated with international growth investors, (b) parallel non-dilutive support via Innovate UK Smart Grants or Innovation Loans to extend runway between rounds, or (c) eventual exit via trade sale or IPO — the long-hold nature of patient capital is designed to support these multi-year journeys rather than push for early liquidity.
Funding context
This is equity, not grant. Expect dilution, board involvement, full investor diligence and a multi-year relationship. British Patient Capital's remit specifically addresses the UK's "patient capital" gap — longer-hold growth funding for companies that need 7–10+ years to scale, particularly in deep-tech and life sciences. Cheque sizes from the underlying funds typically range from low millions to tens of millions, depending on fund and stage.
Eligibility Quick Check
A cautious, rules-based check using only the criteria already published for this programme. Not a guarantee — always verify against the official source.
Frequently asked questions
- Who is eligible to apply for British Patient Capital?
- British Patient Capital is aimed at growth-stage businesses. It is available to applicants in United Kingdom. Industry focus areas include Life Sciences, Technology & Software. Always confirm the live eligibility criteria on the official source page before applying — eligibility rules can change between rounds.
- What does British Patient Capital fund?
- As a equity programme, British Patient Capital typically supports activities consistent with its published objectives (Innovation & R&D, Growth & Equity Capital). Specific eligible costs and project types are defined in the scheme's published guidance — review the official source page for the current list.
- How competitive is British Patient Capital?
- Published competitiveness figures vary by round and are not always disclosed. Treat any scheme with limited published cost as competitive: prepare as if you were one of many strong applicants, and lean on the assessment criteria when building your application.
- What preparation is needed before applying to British Patient Capital?
- Start by reading the official guidance end-to-end and mapping your project against each assessment criterion. Pull together core supporting evidence early — typically organisation details, recent financials, a clear project description, milestones and a budget. Leave time for internal review and, where relevant, partner or advisor sign-off before submission.
- What documents are usually required for British Patient Capital?
- Most schemes ask for organisation details, recent financial information, a project description with milestones, and a budget breakdown. Always check the official source page for the definitive document list for the current round.
- What alternatives exist if British Patient Capital is not a fit?
- The Alternative Routes section above lists related funding paths. As a general rule, look for schemes targeting the same objective or stage from different providers, and consider blending sources (for example combining a grant with a loan or equity) where the project size warrants it.
- How do you apply for British Patient Capital?
- Application routing is set out on the official source page linked above — confirm the current round is open before starting an application.
- When should you start preparing for British Patient Capital?
- Treat preparation as a multi-week process for most schemes. Begin gathering financials, project documentation and supporting evidence as soon as you decide to apply — leaving preparation to the final week typically shows in the quality of the application.
- What happens after you apply to British Patient Capital?
- Applications are typically logged, screened for eligibility, then assessed against the published criteria. Be ready to respond quickly to clarification requests during review, and keep contact details up to date so decision notifications are not missed.
- Can British Patient Capital be combined with other funding or support?
- Equity investment is often blended with non-dilutive funding (grants, tax relief) to extend runway between rounds. Read the scheme's published rules on combined funding before committing — the answer changes case-by-case.
- What should applicants do before applying to British Patient Capital?
- Validate that British Patient Capital is genuinely the best fit — the Alternative Routes section above lists other options worth comparing first. Re-read the official guidance and map your project, organisation and budget to each scoring criterion. Walk through the Eligibility section line by line and gather evidence for every requirement. Speak to anyone in your network who has been through this scheme recently — round-by-round priorities and assessor focus shift.
- What makes a strong application to British Patient Capital?
- Strong British Patient Capital applications evidence fit against every published criterion rather than restating the project's ambition. Use concrete numbers, dated milestones and named partners wherever possible — assessors reward specificity. Make the link to Innovation & R&D and Growth & Equity Capital explicit; do not leave assessors to infer it.
- When might another funding route be more suitable than British Patient Capital?
- If you would prefer to avoid dilution and the project qualifies as R&D, grants and tax reliefs can extend runway without giving up ownership. See the Alternative Routes section above for specific suggestions.
- What happens after British Patient Capital is awarded?
- Funded organisations typically sign a grant or facility agreement that sets out drawdown conditions, reporting cadence and any claw-back triggers. Plan for periodic progress reports, evidence of spend and — for larger awards — independent monitoring or audit.
- How should organisations prepare supporting evidence for British Patient Capital?
- Gather evidence in the order assessors will read it: organisation legitimacy first, then eligibility, then project fit, then budget and impact. Even where a document list is not published, prepare financials, a project plan with milestones, and budget evidence as a baseline. Where claims are quantitative (job creation, emissions reduction, additional R&D spend), document the assumption behind each number.
Related routes
Industries
Objectives
Regions
